Literature DB >> 26309527

Lung cancer cellular apoptosis induced by recombinant human endostatin gold nanoshell-mediated near-infrared thermal therapy.

Haiqing Luo1, Meng Xu2, Xinhai Zhu2, Jianfu Zhao2, Shiqing Man3, Haoran Zhang3.   

Abstract

AIMS AND
BACKGROUND: Endostatin can inhibit tumor endothelial cell proliferation, angiogenesis, and growth. We aimed to determine the increase in antitumor capabilities of recombinant human endostatin (rhES) when used with a nanocarrier system. The effect of gold nanoshell particles of recombinant human endostatin (G-rhES) with near-infrared (NIR) irradiation on proliferation, inhibition, and apoptosis of A549 lung cancer cells was studied.
MATERIALS AND METHODS: Gold nanoshell particles were prepared. Endostatin was connected with the bond A-U through surface modification by bioconjugation of core-shell structured gold nanoshells. The drug targeting endostatin and the synthesized G-rhES were successfully connected. G-rhES inhibited proliferation of A549 lung cancer cells, as detected using tetrazolium colorimetric assay. Cellular apoptosis was measured by flow cytometry. Mitochondrial membrane potential was determined using a confocal microscope. Morphological changes were studied by atomic force microscopy.
RESULTS: Under irradiation in the 820 nm NIR, G-rhES significantly inhibited the proliferation of A549 lung cancer cells. The underlying mechanism may be related to heat-induced apoptosis and cytotoxicity by NIR absorption, which kills cells directly, thereby indicating that G-rhES have good biocompatibility and pharmacological potency. Characterization of the local structure of lung cancer cells showed that G-rhES targeted surface receptors that may serve an apoptotic function under NIR exposure. NIR gold nanoshell particles showed synergism with endostatin, which may be related to hyperthermia-increased cytotoxicity and the apoptotic effect of endostatin.
CONCLUSION: These data suggest that G-rhES can enhance the inhibition of tumor growth. The new treatment strategy of G-rhES combined with thermal therapy may lead to lung cancer remission. The potential benefits of G-rhES are being considered for clinical evaluation.

Entities:  

Keywords:  Gold nanoshells; lung cancer; recombinant human endostatin

Year:  2015        PMID: 26309527      PMCID: PMC4537996     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

Review 1.  Drug delivery systems: past, present, and future.

Authors:  Rubiana M Mainardes; Luciano P Silva
Journal:  Curr Drug Targets       Date:  2004-07       Impact factor: 3.465

2.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

3.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.

Authors:  Nadine Wong Shi Kam; Michael O'Connell; Jeffrey A Wisdom; Hongjie Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

4.  Reversal effect of Stephania tetrandra-containing Chinese herb formula SENL on multidrug resistance in lung cancer cell line SW1573/2R120.

Authors:  Meng Xu; Liang-He Sheng; Xi-Hai Zhu; Shi-Bin Zeng; Guo-Jun Zhang
Journal:  Am J Chin Med       Date:  2010       Impact factor: 4.667

Review 5.  Targeting nanoparticles to cancer.

Authors:  M Wang; M Thanou
Journal:  Pharmacol Res       Date:  2010-04-07       Impact factor: 7.658

6.  Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases.

Authors:  M Salerno; E Cenni; C Fotia; S Avnet; D Granchi; F Castelli; D Micieli; R Pignatello; M Capulli; N Rucci; A Angelucci; A Del Fattore; A Teti; N Zini; A Giunti; N Baldini
Journal:  Curr Cancer Drug Targets       Date:  2010-11       Impact factor: 3.428

7.  Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria.

Authors:  Katalin Nagy; Kinga Székely-Szüts; Kamel Izeradjene; Leslie Douglas; Mike Tillman; Helga Barti-Juhász; Massimo Dominici; Carlotta Spano; Gian Luca Cervo; Pierfranco Conte; Janet A Houghton; Rudolf Mihalik; László Kopper; István Peták
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

8.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

Review 9.  Personalizing therapy with targeted agents in non-small cell lung cancer.

Authors:  Rodrigo Dienstmann; Pablo Martinez; Enriqueta Felip
Journal:  Oncotarget       Date:  2011-03

10.  Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.

Authors:  Meng Xu; Lianghe Sheng; Xinhai Zhu; Shibin Zeng; Dexiang Chi; Guo-Jun Zhang
Journal:  Tumori       Date:  2010 May-Jun
View more
  5 in total

Review 1.  Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells.

Authors:  Sylvie Ricard-Blum; Sylvain D Vallet
Journal:  Front Pharmacol       Date:  2016-02-04       Impact factor: 5.810

Review 2.  The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering.

Authors:  Abbas Mohajeri; Sarvin Sanaei; Farhad Kiafar; Amir Fattahi; Majid Khalili; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2017-04-13

Review 3.  Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches.

Authors:  Harman Saman; Syed Shadab Raza; Shahab Uddin; Kakil Rasul
Journal:  Cancers (Basel)       Date:  2020-05-06       Impact factor: 6.639

4.  Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.

Authors:  Qiusha Tang; Mudan Lu; Daozhen Chen; Peidang Liu
Journal:  Int J Nanomedicine       Date:  2015-11-18

5.  Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system.

Authors:  Siwen Li; Yuxi Liu; Yalan Rui; Liping Tang; Samuel Achilefu; Yueqing Gu
Journal:  Theranostics       Date:  2018-04-03       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.